首页|期刊导航|Cancer Innovation|Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers

Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers

Haixia Cheng Guangwen Yuan Leilei Liang Tiantian Wang Jiarun Zhu Hongying Yang Zhendiao Zhou Pei Wang Qianqian Song Yuchen Jiao Mei Liu Lingying Wu

Cancer Innovation2025，Vol.4Issue(4)：P.70-80,11.

Cancer Innovation2025，Vol.4Issue(4)：P.70-80,11.DOI:10.1002/cai2.70014

Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers

Haixia Cheng ¹Guangwen Yuan ²Leilei Liang ²Tiantian Wang ²Jiarun Zhu ¹Hongying Yang ³Zhendiao Zhou ¹Pei Wang ¹Qianqian Song ¹Yuchen Jiao ¹Mei Liu ¹Lingying Wu²

作者信息

1. Laboratory of Cell and Molecular Biology&State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
2. Department of Gynecologic Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
3. Peking University Cancer Hospital Yunnan Hospital/Yunnan Provincial Cancer Hospital/The Third Affiliated Hospital of Kunming Medical University,Kunming,Yunnan,China
折叠

摘要

关键词

circulating tumor DNA/copy number alterations/ovarian cancer/TP53 mutations

分类

医药卫生

引用本文复制引用

Haixia Cheng,Guangwen Yuan,Leilei Liang,Tiantian Wang,Jiarun Zhu,Hongying Yang,Zhendiao Zhou,Pei Wang,Qianqian Song,Yuchen Jiao,Mei Liu,Lingying Wu..Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers[J].Cancer Innovation,2025,4(4):P.70-80,11.

基金项目

supported by the National Key R&D Program of China(Grant No.2016YFC13037040) （Grant No.2016YFC13037040）

the Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences(Grant No.2022-RC310-08). （Grant No.2022-RC310-08）

Cancer Innovation

ISSN：2770-9191

访问量0

下载量0

段落导航